A food-choice mobile app for people with advanced chronic kidney disease
Tests a dining-out food guide app in people with chronic kidney disease.
Plain-language title generated from the registry record
Registry title: Fostering Self-Empowerment in CKD Patients Through Food Choice Mapping
Key facts
- Where
- Singapore, SingaporeSee the site
Where in Singapore
- Singapore Institute of TechnologySingapore, SingaporeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Singapore Institute of Technology
- Trial code
- NCT07804316
- Record updated
- 4 September 2026
- Original description
This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include:Read full original descriptionShow less
Fostering Self-Empowerment in Kidney Disease Patients Through Food Choice Mapping: A Pilot Study
This project aims to develop mapping of food choices available for chronic kidney disease (CKD) patients when dining out in Singapore. Following the mapping, a mobile application will be developed based on renal dining out food map mobile application (RENDOFOMAP) and trialed on patients with CKD. The specific aims of the project include:
1. Mapping out food choices suitable for patients with CKD when dining out in Singapore which will eventually be translated into a mobile application incorporating simple AI functionality. 2. To evaluate the impact of using RENDOFOMAP on self-empowerment, quality of life, nutritional status, and serum biochemistry in patients with CKD. 3. To evaluate the acceptability and user experience of RENDOFOMAP
Participants with CKD will use the newly developed mobile application to find out if there is improvement in self-empowerment, quality of life, nutritional status, and serum biochemistry.
Inclusion: Are fluent in English. This is necessary to ensure clear communication and understanding of study procedures and materials; Adequate proficiency in using smartphone i.e. downloading app, taking photo, completing e-forms within the mobile applications. This is essential for participants to effectively use the mobile application being tested; Diagnosed with CKD Stage 3B-5. This targets the specific patient population that the study aims to benefit.
Exclusion: Diagnosis of cognitive deficit or neurological disorder. These conditions could impair the ability to follow study procedures or provide reliable data; Newly initiated on dialysis or planning for dialysis within the next 6 months. These patients may have rapidly changing health conditions that could affect study outcomes; Decompensated liver cirrhosis. This condition could complicate the interpretation of study results; Pregnant and lactating. These conditions could introduce additional variables that affect study outcomes; Uncontrolled diabetes (HbA1c>8.5%). This condition could introduce additional health risks and confound study results; Only fluent in languages other than English. This could hinder effective communication and understanding of the study; Recent hypoglycemic episodes. This could pose a safety risk during the study; Inability to provide consent. This ensures that all participants can legally and ethically participate in the study.